Neelie Kroes, the European Commissioner for Competition, concluded her 10-month investigation into the pharmaceutical industry by concluding it "does not work as well as it should" and had cost 17 member states €3bn (£2.5bn) between 2000 and 2007 by limiting the availability of cheaper generic drugs.
Ms Kroes – whose inquiry began in January with raids at some of Europe's largest drugs companies, including GlaxoSmithKline in the UK – warned that the EC may now launch anti-trust proceedings against individual companies.
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.